(Press-News.org) UNDER EMBARGO UNTIL 23.30 UK TIME ON SUNDAY 6TH APRIL 2025
New study investigates effects of ADHD medications on the heart
A new study led by the University of Southampton has found that medications for ADHD have overall small effects on blood pressure and heart rate after weeks or a few months of use.
There have been concerns about the side effects of ADHD medications but the new findings, coupled with other studies, suggest that the benefits of taking these medications outweigh the risks, while highlighting the need for careful monitoring.
The study, published in The Lancet Psychiatry, conducted the largest and most comprehensive analysis of the cardiovascular effects of ADHD medications based on the results of randomised controlled trials - the most rigorous type of clinical study to assess medication effects.
Professor Samuele Cortese, senior lead author of the study from the University of Southampton said: “When it comes to taking any medication, risks and benefits should always be assessed together. We found an overall small increase in blood pressure and pulse for the majority of children taking ADHD medications.
“Other studies show clear benefits in terms of reductions in mortality risk and improvement in academic functions, as well as a small increased risk of hypertension, but not other cardiovascular diseases. Overall, the risk-benefit ratio is reassuring for people taking ADHD medications.”
The study was funded by the National Institute for Health and Care Research (NIHR), within the framework of the NIHR Research Professorships scheme to Professor Samuele Cortese, with Dr Luis Farhat (University of São Paulo, Brazil) as first author and Professor Alexis Revet (University of Toulouse, France) as co-senior author.
It is estimated that attention-deficit/hyperactivity disorder (ADHD) affects around 4 per cent of children in the UK. Of these, around 45 per cent are treated with medication.
The international team of investigators analysed data from 102 randomized controlled trials, including a total of 22,702 participants with ADHD. They used an advanced statistical approach - network meta-analysis - that allowed them to compare the effects of several medications, even when the medications were not directly compared in the trials included in the analysis.
They found that all ADHD medications were generally associated with overall small effects on blood pressure, heart rate, and ECG parameters. With the exception of guanfacine (which leads to decreased blood pressure and heart rate), other medications led to increases in the values of these parameters.
No significant differences were found between stimulants (including methylphenidate and amphetamine) and non-stimulants (atomoxetine and viloxazine) with regard to their effects on blood pressure and heart rate.
“Our findings should inform future clinical guidelines, stressing the need to systematically monitor blood pressure and heart rate, both for stimulants and non-stimulants. This should be particularly relevant for practitioners who might assume that only stimulants have a negative effect on the cardiovascular system,” said Dr Farhat.
The researchers say that those with existing heart conditions should discuss the side effects of ADHD medications with a specialist cardiologist before starting treatment.
Professor Revet added: “Our findings, based on randomised controlled trials that tend to be of short duration due to ethical issues, should be complemented by results from real-world, longer-term studies.”
The research team will now look to see if some groups might be more vulnerable to cardiovascular side effects than others.
NIHR Research Professor Cortese concluded: “While our findings are informative at the group level, that is, on average, we cannot exclude that a subgroup of individuals may have a higher risk of more substantial cardiovascular alterations.
“While it is currently not possible to identify those individuals at higher risk, efforts based on precision medicine approaches will hopefully provide important insights in the future.”
Comparative cardiovascular safety of medications for attention-deficit/hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis is published in The Lancet Psychiatry and is available online.
Ends
Contact
Steve Williams, Media Manager, University of Southampton, press@soton.ac.uk or 023 8059 3212.
Notes for editors
Comparative cardiovascular safety of medications for attention-deficit/hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis will be published in The Lancet Psychiatry. An advanced copy is available upon request. It will be published here after the embargo lifts: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00062-8/fulltext
For Interviews with Professor Samuele Cortese please contact Steve Williams, Media Manager, University of Southampton press@soton.ac.uk or 023 8059 3212.
Additional information
The University of Southampton drives original thinking, turns knowledge into action and impact, and creates solutions to the world’s challenges. We are among the top 100 institutions globally (QS World University Rankings 2025). Our academics are leaders in their fields, forging links with high-profile international businesses and organisations, and inspiring a 22,000-strong community of exceptional students, from over 135 countries worldwide. Through our high-quality education, the University helps students on a journey of discovery to realise their potential and join our global network of over 200,000 alumni. www.southampton.ac.uk
www.southampton.ac.uk/news/contact-press-team.page
Follow us on X: https://twitter.com/UoSMedia
About the NIHR
The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research. We do this by:
• Funding high quality, timely research that benefits the NHS, public health and social care;
• Investing in world-class expertise, facilities and a skilled delivery workforce to translate discoveries into improved treatments and services;
• Partnering with patients, service users, carers and communities, improving the relevance, quality and impact of our research;
• Attracting, training and supporting the best researchers to tackle complex health and social care challenges;
• Collaborating with other public funders, charities and industry to help shape a cohesive and globally competitive research system;
• Funding applied global health research and training to meet the needs of the poorest people in low and middle income countries.
NIHR is funded by the Department of Health and Social Care. Its work in low and middle income countries is principally funded through UK international development funding from the UK government.
END
New study investigates effects of ADHD medications on the heart
2025-04-06
ELSE PRESS RELEASES FROM THIS DATE:
Research to tackle Prymnesium algal blooms which affect fish populations
2025-04-06
A scientific initiative to combat harmful Prymnesium algal blooms in the Broads is gaining fresh momentum, thanks to a renewed collaboration between the University of East Anglia (UEA), the Environment Agency, the Broads Authority, and the Norfolk pike angling community.
Prymnesium algal blooms can occur on the Broads and produce toxins that threaten fish stocks, local biodiversity, and East Anglia’s thriving angling industry, which contributes more than £100 million annually to the local economy.
The golden algae Prymnesium parvum is therefore of significant research interest to ...
Climate and health litigation mounting in Australia as exposure to heatwaves grows
2025-04-06
Australia’s exposure to extreme heat continues to grow while the country has emerged as a global hotspot for climate change litigation, according to the latest MJA–Lancet Countdown report.
Released today, the report reveals Australia has experienced a 37 per cent increase in excess heat factor over the past 20 years.
Lead author and Director of the Lancet Countdown Centre in Oceania, Professor Paul Beggs from Macquarie University, says these findings underscore the importance of long-term tracking of climate hazards and exposures in Australia.
“The frequency of health-damaging heat has increased substantially since the 1970s," says Professor Beggs.
The ...
Young females more likely to experience higher social anxiety due to excessive smartphone use than other genders
2025-04-06
EMBAROGED UNTIL SUNDAY 6TH APRIL AT 08:00 CEST
YOUNG FEMALES MORE LIKELY TO EXPERIENCE HIGHER SOCIAL ANXIETY DUE TO EXCESSIVE SMARATPHONE USE THAN OTHER GENDERS
Sunday 6th April 08:00 CEST - A new study presented today at the European Psychiatric Association Congress 2025 reveals that gender plays a significant role in excessive and problematic (psychological or behavioural dependence)1 smartphone use, with young females more likely to experience higher social anxiety than other genders. In the study, it was also found that gender was significantly linked to the amount of time spent using smartphones ...
New research boosts future whooping cough vaccines
2025-04-04
Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the introduction of vaccines in the 1940s. In the decades since, the bacterial disease was nearly eradicated in the U.S., with fatalities falling to double digits each year.
But the disease has made a troubling comeback in recent years as vaccine coverage declined after the COVID-19 pandemic. In 2024, several outbreaks left public health officials and hospitals scrambling to accommodate a sudden influx of patients, primarily infants, who are often too young to be vaccinated and suffer the most severe symptoms.
Now, new research from The University of Texas at Austin could aid ...
Mechanistic understanding could enable better fast-charging batteries
2025-04-04
MADISON — Fast-charging lithium-ion batteries are ubiquitous, powering everything from cellphones and laptops to electric vehicles. They’re also notorious for overheating or catching fire.
Now, with an innovative computational model, a University of Wisconsin–Madison mechanical engineer has gained new understanding of a phenomenon that causes lithium-ion batteries to fail.
Developed by Weiyu Li, an assistant professor of mechanical engineering at UW–Madison, the model explains lithium plating, in which fast charging triggers metallic lithium to build up on the surface of a battery’s anode, causing the battery to ...
No bones about it: new details about skeletal cell aging revealed
2025-04-04
It's no coincidence that our bodies feel a little creakier as we age. The trillions of cells that make up our skeleton age too, and some change in ways that weaken the very structure of our bones.
Scientists and researchers around the globe are investigating a series of mysteries about what happens to our bones over time. In a new study, a team led by The University of Texas at Austin, in collaboration with Mayo Clinic and Cedars-Sinai Medical Center just made a major break in the case. New research found that osteocytes undergo dramatic structural and functional changes ...
UNM scientists discover how nanoparticles of toxic metal used in MRI scans infiltrate human tissue
2025-04-04
University of New Mexico researchers studying the health risks posed by gadolinium, a toxic rare earth metal used in MRI scans, have found that oxalic acid, a molecule found in many foods, can generate nanoparticles of the metal in human tissues.
In a new paper published in the journal Magnetic Resonance Imaging, a team led by Brent Wagner, MD, professor in the Department of Internal Medicine in the UNM School of Medicine, sought to explain the formation of the nanoparticles, which have been associated with serious health problems in the kidneys and other organs.
“The worst disease caused by MRI contrast agents is nephrogenic systemic ...
UMaine research examines best methods for growing Atlantic sea scallops
2025-04-04
A new study from the University of Maine’s Aquaculture Research Institute (ARI) and Darling Marine Center is helping to refine best practices for growing Atlantic sea scallops (Placopecten magellanicus), a species of increasing interest to Maine’s aquaculture sector.
Published in the academic journal Aquaculture, the research compares two scallop farming methods, ear-hanging and lantern net culture, over a complete grow-out cycle to determine which approach yields the best results for commercial growers. The study, led by UMaine ...
Medical cannabis could speed recovery, especially at community recovery homes
2025-04-04
A new pilot study from UBC Okanagan and Thompson Rivers University examined how medically supervised cannabis use in a residential recovery home may support people in treatment for substance use challenges.
Participants reported that cannabis helped them manage pain, anxiety, depression and sleep issues—key symptoms that can complicate recovery.
"Our findings suggest medical cannabis could play a meaningful role in reducing cravings and improving retention in recovery programs," says ...
Study assesses U.S. image amid weakening of democracy
2025-04-04
The erosion of democracy in the U.S. has been a topic of concern in recent years, especially after protesters stormed the U.S. Capitol on Jan. 6, 2021, in an attempt to block the certification of Joe Biden's election as president. Most of the academic studies on democratic backsliding, however, have focused on public opinion within the U.S. and have not looked at global public opinion.
How favorably others view the U.S. is part of the country's "soft power"—a term coined by Joseph Nye at Harvard University in the 1980s. It refers to a country's ability to influence other countries’ policy ...